Humana
Mallinckrodt files for bankruptcy protection in the US
Bankruptcy filing will reduce debts related to legal liabilities
US piles pressure on Mallinckrodt over alleged Acthar fraud
Drugmaker allegedly underpaid rebates owed to Medicaid
Mallinckrodt reaches tentative $1.6bn opioid settlement
Agreement reached with a plaintiff's executive committee
Humana lawsuit targets Mallinckrodt’s ‘billion-dollar golden goose’
Latest twist in long story of Acthar
Mallinckrodt doses first patient in muscular dystrophy trial
Repurposed drug could help delay decline in muscle function
Mallinckrodt pays $1.2bn for Sucampo Pharma
The Irish group will acquire Amitizia, Rescula and a pipeline of rare disease projects
Amgen signs real world study and mobile data partnership
Will work with health and wellbeing group Humana on risk prevention
Ireland’s Mallinckrodt buys US regenerative medicine firm
Stratatech’s StrataGraft in phase III testing for burns treatment
Ireland’s Mallinckrodt makes $1.3bn immunotherapy purchase
Will acquire Therakos to further boost its hospital drug portfolio
Mallinckrodt cuts $5.6bn deal to buy Questcor
Irish company continues move from medical imaging to pharma products
Mallinckrodt offers $1.3bn for Cadence Pharma
Deal would include injectable painkiller Ofirmev